MSD
The Executive Director (Distinguished Scientist) leads the planning and execution of late‑stage clinical research for new and marketed medicines in the Atherosclerosis section, overseeing the full development cycle from Phase 2 to Phase V. This role manages cross‑functional product development teams, directs clinical trial strategy and execution, and provides scientific leadership both internally and with external key opinion leaders.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
72% above the average for this role
MSD ends takeover talks with Revolution Medicines
1 month ago
Executive Director (Distinguished Scientist)
Merck & Co., Inc.
Senior Director, Clinical Research, Atherosclerosis
Merck & Co., Inc.
Senior Director, Clinical Research, Atherosclerosis
Merck & Co., Inc.
Executive Director (Distinguished Scientist)
Merck & Co., Inc.
Clinical Director (Principal Scientist)
Merck & Co., Inc.
Senior Director (Sr. Principal Scientist)
Merck & Co., Inc.